Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Published: 2026-04-29 16:01:08 ET NVAX

Published on 04/29/2026 at 04:01 pm EDT

GAITHERSBURG, Md., April 29, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2026 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Wednesday, May 6, 2026. Details of the event and replay are as follows:

Conference call details:

Date:

May 6, 2026

Time:

8:30 a.m. ET

URL to register phone:

Register Here

Dial-in number:

(888) 880-3330 (U.S.) or

(+1) (646) 357-8766 (International)

Webcast:

ir.novavax.com/events

Replay details:

Date:

Available starting at 11:30 a.m. ET, May 6, 2026, until 11:59 p.m. ET, May 13, 2026

Dial-in number:

(800) 770-2030 (U.S.) or

(+1) (609) 800-9909 (International)

Passcode:

1309751#

Webcast:

ir.novavax.com/events, until June 6, 2026

About NovavaxNovavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's growth strategy focuses on maximizing the impact of its cutting-edge technology by forging strategic partnerships for its Matrix-M adjuvant and R&D assets. Please visit novavax.com and LinkedIn for more information.

Contacts:

InvestorsJim [email protected]

MediaYvonne [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-first-quarter-2026-financial-results-on-may-6-2026-302757475.html

SOURCE Novavax, Inc.